Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS
Status:
Recruiting
Trial end date:
2026-08-01
Target enrollment:
Participant gender:
Summary
multi-center, prospective, randomized, open-label phase III
Phase:
Phase 3
Details
Lead Sponsor:
Asan Medical Center
Collaborators:
Ajou University School of Medicine Chung-Ang University Hosptial, Chung-Ang University College of Medicine Gachon University Gil Medical Center Gangnam Severance Hospital Hallym University Medical Center Inje University Kangbuk Samsung Hospital Korea University Guro Hospital Kyung Hee University Hospital Kyungpook National University Hospital Roche Pharma AG Seoul National University Boramae Hospital Seoul National University Bundang Hospital Ulsan University Hospital